Search Results

There are 32026 results for: content related to: Survival advantage with decitabine versus intensive chemotherapy in patients with higher risk myelodysplastic syndrome

  1. You have free access to this content
    Evolution of decitabine development

    Cancer

    Volume 112, Issue 11, 1 June 2008, Pages: 2341–2351, Elias Jabbour, Jean-Pierre Issa, Guillermo Garcia-Manero and Hagop Kantarjian

    Article first published online : 8 APR 2008, DOI: 10.1002/cncr.23463

  2. You have free access to this content
    Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo

    International Journal of Cancer

    Volume 131, Issue 1, 1 July 2012, Pages: 18–29, Oscar Alcazar, Susan Achberger, Wayne Aldrich, Zhenbo Hu, Soledad Negrotto, Yogen Saunthararajah and Pierre Triozzi

    Article first published online : 6 SEP 2011, DOI: 10.1002/ijc.26320

  3. Safety and clinical activity of 5-aza-2′-deoxycytidine (decitabine) with or without Hyper-CVAD in relapsed/refractory acute lymphocytic leukaemia

    British Journal of Haematology

    Volume 167, Issue 3, November 2014, Pages: 356–365, Christopher B. Benton, Deborah A. Thomas, Hui Yang, Farhad Ravandi, Michael Rytting, Susan O'Brien, Anna R. Franklin, Gautam Borthakur, Samuel Dara, Monica Kwari, Sherry R. Pierce, Elias Jabbour, Hagop Kantarjian and Guillermo Garcia-Manero

    Article first published online : 26 JUL 2014, DOI: 10.1111/bjh.13050

  4. You have free access to this content
    Update of the decitabine experience in higher risk myelodysplastic syndrome and analysis of prognostic factors associated with outcome

    Cancer

    Volume 109, Issue 2, 15 January 2007, Pages: 265–273, Hagop M. Kantarjian, Susan O'Brien, Jianqin Shan, Ahmed Aribi, Guillermo Garcia-Manero, Elias Jabbour, Farhad Ravandi, Jorge Cortes, Jan Davisson and Jean-Pierre Issa

    Article first published online : 28 NOV 2006, DOI: 10.1002/cncr.22376

  5. Treatment with the cancer drugs decitabine and doxorubicin induces human skin keratinocytes to express Oct4 and the OCT4 regulator mir-145

    The Journal of Dermatology

    Volume 39, Issue 7, July 2012, Pages: 617–624, Sathivel CHINNATHAMBI, Susan WIECHERT, Ann TOMANEK-CHALKLEY, Michael C. WINTER and Jackie R. BICKENBACH

    Article first published online : 9 APR 2012, DOI: 10.1111/j.1346-8138.2012.01553.x

  6. A phase 1 clinical trial of vorinostat in combination with decitabine in patients with acute myeloid leukaemia or myelodysplastic syndrome

    British Journal of Haematology

    Volume 167, Issue 2, October 2014, Pages: 185–193, Mark Kirschbaum, Ivana Gojo, Stuart L. Goldberg, Christopher Bredeson, Lisa A. Kujawski, Allen Yang, Peter Marks, Paul Frankel, Xing Sun, Alessandra Tosolini, Joseph E. Eid, Gregory M. Lubiniecki and Jean-Pierre Issa

    Article first published online : 8 JUL 2014, DOI: 10.1111/bjh.13016

  7. Results of phase 2 randomized study of low-dose decitabine with or without valproic acid in patients with myelodysplastic syndrome and acute myelogenous leukemia

    Cancer

    Jean-Pierre Issa, Guillermo Garcia-Manero, Xuelin Huang, Jorge Cortes, Farhad Ravandi, Elias Jabbour, Gautam Borthakur, Mark Brandt, Sherry Pierce and Hagop M. Kantarjian

    Article first published online : 21 OCT 2014, DOI: 10.1002/cncr.29085

  8. You have free access to this content
    Second complete remission in an elderly patient with acute myeloid leukemia retreated with decitabine

    American Journal of Hematology

    Volume 81, Issue 7, July 2006, Pages: 543–545, Amanda F. Cashen, Hollie Devine and John DiPersio

    Article first published online : 5 JUN 2006, DOI: 10.1002/ajh.20626

  9. You have free access to this content
    Phase I trial of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylation

    British Journal of Haematology

    Volume 150, Issue 2, July 2010, Pages: 189–195, Kristie A. Blum, Zhongfa Liu, David M. Lucas, Ping Chen, Zhiliang Xie, Robert Baiocchi, Donald M. Benson, Steven M. Devine, Jeffrey Jones, Leslie Andritsos, Joseph Flynn, Christoph Plass, Guido Marcucci, Kenneth K. Chan, Michael R. Grever and John C. Byrd

    Article first published online : 29 APR 2010, DOI: 10.1111/j.1365-2141.2010.08213.x

  10. You have free access to this content
    Myelodysplastic syndromes: 2012 update on diagnosis, risk-stratification, and management

    American Journal of Hematology

    Volume 87, Issue 7, July 2012, Pages: 692–701, Guillermo Garcia-Manero

    Article first published online : 14 JUN 2012, DOI: 10.1002/ajh.23264

  11. Inhibition of bladder cancer invasion by Sp1-mediated BTG2 expression via inhibition of DNA methyltransferase 1

    FEBS Journal

    Volume 281, Issue 24, December 2014, Pages: 5581–5601, Preethi Devanand, Sun Il Kim, Yong Won Choi, Seung Soo Sheen, Hyunee Yim, Min Sook Ryu, Se Joong Kim, Wun-Jae Kim and In Kyoung Lim

    Article first published online : 30 OCT 2014, DOI: 10.1111/febs.13099

  12. You have free access to this content
    Decitabine improves patient outcomes in myelodysplastic syndromes

    Cancer

    Volume 106, Issue 8, 15 April 2006, Pages: 1794–1803, Hagop Kantarjian, Jean-Pierre J. Issa, Craig S. Rosenfeld, John M. Bennett, Maher Albitar, John DiPersio, Virginia Klimek, James Slack, Carlos de Castro, Farhad Ravandi, Richard Helmer III, Lanlan Shen, Stephen D. Nimer, Richard Leavitt, Azra Raza and Hussain Saba

    Article first published online : 13 MAR 2006, DOI: 10.1002/cncr.21792

  13. You have free access to this content
    Epigenetic therapy in myelodysplastic syndromes

    European Journal of Haematology

    Volume 84, Issue 6, June 2010, Pages: 463–473, Caterina Musolino, Emanuela Sant’Antonio, Giuseppa Penna, Andrea Alonci, Sabina Russo, Angela Granata and Alessandro Allegra

    Article first published online : 23 FEB 2010, DOI: 10.1111/j.1600-0609.2010.01433.x

  14. You have free access to this content
    Chronic myelogenous leukemia in nonlymphoid blastic phase

    Cancer

    Volume 86, Issue 12, 15 December 1999, Pages: 2632–2641, Stefano Sacchi, Hagop M. Kantarjian, Susan O'Brien, Jorge Cortes, Mary Beth Rios, Francis J. Giles, Miloslav Beran, Charles A. Koller, Michael J. Keating and Moshe Talpaz

    Article first published online : 20 NOV 2000, DOI: 10.1002/(SICI)1097-0142(19991215)86:12<2632::AID-CNCR7>3.0.CO;2-A

  15. You have free access to this content
    The DNA methyltransferase inhibitors zebularine and decitabine induce mitochondria-mediated apoptosis and DNA damage in p53 mutant leukemic T cells

    International Journal of Cancer

    Volume 130, Issue 5, 1 March 2012, Pages: 1195–1207, María J. Ruiz-Magaña, Jose M. Rodríguez-Vargas, Jorge C. Morales, Manuel A. Saldivia, Klaus Schulze-Osthoff and Carmen Ruiz-Ruiz

    Article first published online : 21 JUL 2011, DOI: 10.1002/ijc.26107

  16. You have full text access to this Open Access content
    Phase I/II study of decitabine in patients with myelodysplastic syndrome: A multi-center study in Japan

    Cancer Science

    Volume 103, Issue 10, October 2012, Pages: 1839–1847, Yasuhiro Oki, Yutaka Kondo, Kazuhito Yamamoto, Michinori Ogura, Masanobu Kasai, Yukio Kobayashi, Takashi Watanabe, Naokuni Uike, Kazuma Ohyashiki, Shin-ichiro Okamoto, Kazunori Ohnishi, Akihiro Tomita, Yasushi Miyazaki, Kaoru Tohyama, Harumi Y. Mukai, Tomomitsu Hotta and Masao Tomonaga

    Article first published online : 14 SEP 2012, DOI: 10.1111/j.1349-7006.2012.02386.x

  17. You have free access to this content
    Myelodysplastic syndromes: 2014 update on diagnosis, risk-stratification, and management

    American Journal of Hematology

    Volume 89, Issue 1, January 2014, Pages: 97–108, Guillermo Garcia-Manero

    Article first published online : 24 JAN 2014, DOI: 10.1002/ajh.23642

  18. You have free access to this content
    DNA hypo-methylating agents and sickle cell disease

    British Journal of Haematology

    Volume 126, Issue 5, September 2004, Pages: 629–636, Yogen Saunthararajah, Donald Lavelle and Joseph DeSimone

    Article first published online : 5 JUL 2004, DOI: 10.1111/j.1365-2141.2004.05064.x

  19. You have free access to this content
    Outcome of patients with myelodysplastic syndrome after failure of decitabine therapy

    Cancer

    Volume 116, Issue 16, 15 August 2010, Pages: 3830–3834, Elias Jabbour, Guillermo Garcia-Manero, Nicolas Batty, Jenny Shan, Susan O'Brien, Jorge Cortes, Farhad Ravandi, Jean-Pierre Issa and Hagop Kantarjian

    Article first published online : 17 MAY 2010, DOI: 10.1002/cncr.25247

  20. You have free access to this content
    Results of decitabine (5-aza-2′deoxycytidine) therapy in 130 patients with chronic myelogenous leukemia

    Cancer

    Volume 98, Issue 3, 1 August 2003, Pages: 522–528, Hagop M. Kantarjian, Susan O'Brien, Jorge Cortes, Francis J. Giles, Stefan Faderl, Jean-Pierre Issa, Guillermo Garcia-Manero, Mary Beth Rios, Jianqin Shan, Michael Andreeff, Michael Keating and Moshe Talpaz

    Article first published online : 13 JUN 2003, DOI: 10.1002/cncr.11543